VITASPRING BIOMEDICAL CO., LTD.: cashflow_investing
| Value | {"amount": -72997, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-02-01 – 2022-01-31 |
| Status | current |
| Entity | VITASPRING BIOMEDICAL CO., LTD. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:23:16.246968+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8fafc028-e0e4-4dd4-8206-028b044083c1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001640334-25-002237Retrieved: 2026-08-19T17:23:16.246968+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001697884/cashflow-investing/2022-01-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8fafc028-e0e4-4dd4-8206-028b044083c1
History
- supersedes {"amount": 72997, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0001697884-22-000006)